Metabolic and hormonal response to physical exercise during beta 1-selective and non-selective beta-blockade. 1982

M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa

The effects of a beta 1-selective (metoprolol, 150 mg per day) and a non-selective beta-blocking agent (propranolol, 120 mg per day) on metabolic and hormonal responses to physical exercise (a 30 min bicycle ergometer test) were investigated against placebo in seven healthy male volunteers with a double blind cross-over design. The blood glucose level remained unchanged during placebo, it tended to increase during metoprolol, whereas it decreased during propranolol. Both metoprolol and propranolol counteracted the exercise-induced increase in plasma free fatty acids and caused a slight decrease in muscle glycogenolysis. The increase in blood lactate concentration during exercise was not influenced by beta-blockade. The secretion of glucagon and cortisol was not modified significantly by beta-blockade, whereas the growth hormone response to exercise was promoted equally by both beta-blocking agents. It has been assumed previously that, during treatment with beta-blocking agents, diminished hepatic gluconeogenesis, caused by the lack of lactate or free fatty acids, may result in a decline in blood glucose levels. The present results indicate that an inhibition of beta 2-mediated hepatic glycogenolysis by propranolol may also influence blood glucose homeostasis during exercise.

UI MeSH Term Description Entries
D008066 Lipolysis The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. Lipolyses
D008112 Liver Glycogen Glycogen stored in the liver. (Dorland, 28th ed) Hepatic Glycogen,Glycogen, Hepatic,Glycogen, Liver
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor

Related Publications

M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
May 1981, Zeitschrift fur Kardiologie,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
October 1988, Clinical physiology (Oxford, England),
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
August 1981, European journal of clinical investigation,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
January 1985, British journal of clinical pharmacology,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
February 1987, Diabetes research (Edinburgh, Scotland),
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
January 1981, Acta medica Scandinavica. Supplementum,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
June 2008, The Journal of physiology,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
January 1987, European journal of applied physiology and occupational physiology,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
December 1981, Diabete & metabolisme,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
May 1969, Australasian annals of medicine,
Copied contents to your clipboard!